lamivudine

Lamivudine is a typical antivirus agent of pyrimidine nucleoside , mainly used for the treatment of hepatitis B.

The aim of this clinical trial is to evaluate the efficacy of a combination therapy of lamivudine and vaccine in patients with CHB.

This would be one of the class B drugs (telbivudine or tenofovir) hopefully or lamivudine.

Glaxo, now GlaxoSmithKline, began worldwide lamivudine testing in the mid-1990s and is still studying its long-term usefulness.

Pekarek confirmed that company had given the FDA the long-term treatment data on lamivudine, including the Asian study results.

Objective: To discuss the general rules and characteristics of adverse drug reactions (ADRS) of lamivudine.

Combination of lamivudine with other antiviral agents or immune modulators is likely to be more effective.

Result: There were significant differences in dissolution procession as well as impurities between two lamivudine tablets.

Prof. Stanley Martin Cohen : I don't feel that Lamivudine is an appropriate first-line drug given its very high rates of resistance.

The present invention may be used in simple polar organic phase mode to resolve the medicine antimer of zolmitriptan, lamivudine, etc.

Entecavir has reduced efficacy in patients with lamivudine-resistant HBV, and entecavir resistance may develop in these patients.

The objective is to improve and maintain the antiviral treatment efficacy of lamivudine in chronic hepatitis B.

Conclusion The adjuvant treatment of liver cirrhosis with lamivudine results are satisfactory, is worthy of clinical use.

Lamivudine is the nucleoside analog most widely combined with multiple administrations of vaccine.

Therefore, there is a need for a better definition of the potential role and limitations of lamivudine or similar therapies, used alone.

In this paper we reviewed lamivudine-resistant mechanism, diagnosis and rescue therapy after resistance.

HBeAg negative lamivudine-resistant HBVs, which replicate more efficiently and produce higher viral loads, may become directly cytopathic.

The incremental medical cost was less than 38, 500 RMB per year of life saved compared to shorter treatment duration of lamivudine.

The historical control group consisted of 116 patients who underwent chemotherapy without lamivudine treatment.

We present a patient who developed a contact dermatitis to lamivudine after prolonged exposure.

abstract: Objective: To investigate clinical effect of Adefovior in treatment of Lamivudine resistant patients with hepatitis B.

Lamivudine-resistant mutations were detected in both patients.

Telbivudine is just behind lamivudine, it also has a substantial resistance rate.

Conclusion: The bulk drug quality and production technology may lead to quality differences of lamivudine tablets.

examples of drugs in the class are lamivudine , entecavir and adefovir.

ObjectiveTo evaluate the efficacy and safety of domestic adefovir dipivoxil in patients with hepatitis B resistant to lamivudine.

Were prescribed in 2007 suffering from AIDS, his brand of Nike kit bag in the end there is still a lamivudine.

Typically, neirapine is gien in combination with AZT and lamivudine.

Serum HBV DNA levels were measured prior to lamivudine, at transplantation, and at 12 months post transplantation.

Conclusion: Clinical effect of Adefovior in treatment of Lamivudine resistant patients is good and it is worthy of application.

A USP Lamivudine Resolution Mixture B RS.

That has been demonstrated already for lamivudine and it is the same for drugs like entecavir or entecavir.

With lamivudine, long term rates of resistance are in the 60% to 100% range, depending on the study and the patient profile.

RESULTS: Between February 1996 and October 2004, 147 patients received low-dose HBIG plus lamivudine.

Clinical study of Lamivudine treatment in patients with decompensated cirrhosis

Establishment of a method for detection of lamivudine-resistant mutants in sequence of HBV polymerase gene

A Study of the Interaction Mechanism between Lamivudine and Bovine Serum Albumin

Analysis of three lamivudine-resistant HBV mutants with the method of restriction enzyme digestion and its application

The pilot study on development of lamivudine-resistance oligonucleotide microarray and its reliability in clinical application

The analysis of effectiveness and cost of lamivudine in treatment of chronic hepatitis

Therapeutic and preventive activities of lamivudine on HBV reactivation in HBV carriers with immunodeficiency

Survey of the synthesis of the antiviral drug lamivudine and its analogs

Clinical investigation on occurrence of HBeAg seroconversion during continuous Lamivudine therapy after emergence of HBV YMDD mutation

Clinical experimental research on the treatment of chronic hepatitis-B with the combination of jiudaiqingyuan oral solution and lamivudine

Therapeutic and preventive efficacy of lamivudine in patients with active hepatitis Bin portal hypertension perioperation

The composition ratio of Lamivudine decreased year by year, but the DDDs was always the top 1;

clinical observations on withdrawal symptoms of chronic hepatitis b treated by lamivudine

Optimal lamivudine treatment duration and the relationship between its early response and long term effect

Evaluation of different methods in monitoring YMDD motif mutations associated with lamivudine resistance

Literature Analysis on Lamivudine Adverse Reactions

Clinical therapeutic effect of lamivudine on the active hepatocirrhosis

Application status of Lamivudine in liver transplantation

Effect of plasma exchange combined with lamivudine on dynamics of serum HBV in patients with hepatitis gravis

Lamivudine therapy for children and teenagers with chronic hepatitis B: a long term clinical observation

In vitro anti-porcine reproductive and respiratory syndrome virus effect of Lamivudine

Lamivudine for hepatitis B: antiviral efficacy and viral resistance

The curative effect of combined therapy of oxymatrine and lamivudine on hepatic fibrosis

Clinical study on the effect of combination therapy with lamivudine and emodin against hepatic fibrosis

Studies on the Relationship between Hepatitis Virus level and YMDD Variation in Cases Resistant to Lamivudine

The clinical therapeutic effect of matrine and lamivudine on the active cirrhosis

Pilot study on HBV lamivudine-resistance associated gene and HBV genotype

Preventive Effect of Lamivudine to HBV Hepatitis of Tumor Patients with HBV Infection

Distribution of HBV genotypes in Shandong province and it's relationship with the antiviral effect of lamivudine

Graphical Synthetic Routes of Lamivudine

Clinical research progress on Lamivudine

Lamivudine combined with measles vaccine for chronic HBV infections: 72case report

Short-term Effect of Phyllanthus Compound and Lamivudine in Treating Chronic Hepatitis B: An Observation of 30 Cases

Effect of lamivudine on the quota of liver fibrosis with cirrhosis infected by HBV

A Clinical Effect of Lamivudine and Shuang Jia Wu Ling Capsule on Hepatic Fibrosis

Clinical study on the treatment of 38 cases of decompensation liver cirrhosis by lamivudine

Efficiency Evaluation of Lamivudine in the Treatment of 128 Patients with HBV Infection

Individual therapy for the patients with YMDD mutation in HBV by lamivudine

Progress on Total Synthesis of Lamivudine

Recent research progress in lamivudine, a new anti-HBV agent

Clinical analysis of 71 cases chronic HBV infection treated by lamivudine

The short-term effect of lamivudine on active cirrhosis of liver

Facial edema induced by lamivudine